Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01811992 |
|
Recruitment Status :
Completed
First Posted : March 15, 2013
Last Update Posted : August 31, 2021
|
Sponsor:
University of Michigan Rogel Cancer Center
Collaborator:
Phase One Foundation
Information provided by (Responsible Party):
University of Michigan Rogel Cancer Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | February 2019 |
| Actual Study Completion Date : | January 2021 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):